Matthieu Pelletier-Galarneau, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Perfusion Imaging | 16 | 2023 | 554 | 5.140 |
Why?
|
Positron-Emission Tomography | 31 | 2023 | 6234 | 2.950 |
Why?
|
Fractional Flow Reserve, Myocardial | 5 | 2020 | 290 | 2.600 |
Why?
|
Radiopharmaceuticals | 20 | 2023 | 2645 | 2.280 |
Why?
|
Fluorodeoxyglucose F18 | 12 | 2023 | 2016 | 2.260 |
Why?
|
Cardiomyopathies | 7 | 2023 | 1912 | 2.160 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 11 | 2023 | 1107 | 2.110 |
Why?
|
Coronary Artery Disease | 15 | 2023 | 6487 | 2.040 |
Why?
|
Rubidium Radioisotopes | 6 | 2022 | 85 | 1.970 |
Why?
|
Prosthesis-Related Infections | 4 | 2020 | 538 | 1.920 |
Why?
|
Coronary Circulation | 10 | 2023 | 1572 | 1.900 |
Why?
|
Amyloidosis | 4 | 2023 | 795 | 1.880 |
Why?
|
Atrioventricular Block | 2 | 2023 | 120 | 1.630 |
Why?
|
Myocarditis | 4 | 2023 | 771 | 1.620 |
Why?
|
Endocarditis | 3 | 2020 | 350 | 1.600 |
Why?
|
Coronary Vasospasm | 2 | 2022 | 88 | 1.540 |
Why?
|
Sodium Fluoride | 2 | 2020 | 65 | 1.410 |
Why?
|
Foot Diseases | 2 | 2021 | 143 | 1.400 |
Why?
|
Dipyridamole | 2 | 2020 | 145 | 1.380 |
Why?
|
Sarcoidosis | 3 | 2023 | 506 | 1.360 |
Why?
|
Molecular Imaging | 3 | 2019 | 828 | 1.200 |
Why?
|
Vasodilator Agents | 3 | 2020 | 977 | 1.120 |
Why?
|
Coronary Vessels | 5 | 2021 | 3107 | 1.060 |
Why?
|
Ergonovine | 2 | 2022 | 15 | 1.020 |
Why?
|
Technetium Tc 99m Pyrophosphate | 2 | 2020 | 44 | 0.940 |
Why?
|
Heart Valve Prosthesis | 3 | 2020 | 1488 | 0.880 |
Why?
|
Coronary Angiography | 9 | 2023 | 4577 | 0.860 |
Why?
|
Foot Bones | 1 | 2021 | 24 | 0.770 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2021 | 177 | 0.750 |
Why?
|
Microvascular Angina | 1 | 2020 | 15 | 0.730 |
Why?
|
Organophosphorus Compounds | 1 | 2021 | 215 | 0.730 |
Why?
|
Dobutamine | 1 | 2020 | 123 | 0.720 |
Why?
|
Tellurium | 1 | 2019 | 23 | 0.710 |
Why?
|
Iodine Radioisotopes | 2 | 2023 | 1032 | 0.650 |
Why?
|
Cadmium | 1 | 2019 | 212 | 0.640 |
Why?
|
Blood Vessel Prosthesis | 2 | 2020 | 933 | 0.640 |
Why?
|
Takayasu Arteritis | 1 | 2019 | 96 | 0.610 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2020 | 138 | 0.610 |
Why?
|
Cardiotonic Agents | 1 | 2020 | 535 | 0.580 |
Why?
|
Adenosine | 3 | 2020 | 825 | 0.550 |
Why?
|
Endocarditis, Bacterial | 1 | 2020 | 455 | 0.550 |
Why?
|
Fluorine Radioisotopes | 1 | 2019 | 442 | 0.540 |
Why?
|
Hypercapnia | 1 | 2017 | 260 | 0.530 |
Why?
|
Waiting Lists | 1 | 2020 | 692 | 0.530 |
Why?
|
Zinc | 1 | 2019 | 684 | 0.510 |
Why?
|
Heart | 2 | 2019 | 4467 | 0.510 |
Why?
|
Giant Cell Arteritis | 1 | 2019 | 292 | 0.500 |
Why?
|
Radionuclide Ventriculography | 1 | 2014 | 41 | 0.500 |
Why?
|
Microvessels | 1 | 2019 | 544 | 0.490 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2015 | 83 | 0.490 |
Why?
|
Thorax | 1 | 2017 | 547 | 0.460 |
Why?
|
Breast Neoplasms, Male | 1 | 2015 | 210 | 0.450 |
Why?
|
Gastroparesis | 1 | 2015 | 131 | 0.440 |
Why?
|
Gastric Emptying | 1 | 2015 | 233 | 0.440 |
Why?
|
Angiography | 1 | 2018 | 1639 | 0.420 |
Why?
|
Aorta | 1 | 2020 | 2061 | 0.410 |
Why?
|
Cardiology | 2 | 2022 | 1668 | 0.400 |
Why?
|
Radionuclide Imaging | 2 | 2015 | 2031 | 0.400 |
Why?
|
Predictive Value of Tests | 9 | 2023 | 15076 | 0.400 |
Why?
|
Ticlopidine | 1 | 2017 | 899 | 0.390 |
Why?
|
Microcirculation | 3 | 2021 | 1286 | 0.390 |
Why?
|
Myocardium | 2 | 2021 | 4776 | 0.390 |
Why?
|
Heart Neoplasms | 1 | 2014 | 374 | 0.380 |
Why?
|
Humans | 54 | 2023 | 744343 | 0.370 |
Why?
|
Membrane Potential, Mitochondrial | 3 | 2021 | 297 | 0.360 |
Why?
|
Incidental Findings | 1 | 2015 | 689 | 0.360 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2020 | 1390 | 0.360 |
Why?
|
Bone and Bones | 1 | 2021 | 2575 | 0.360 |
Why?
|
Aortic Valve | 1 | 2020 | 1922 | 0.360 |
Why?
|
Heart Diseases | 1 | 2022 | 2788 | 0.340 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2020 | 1536 | 0.340 |
Why?
|
Heart Transplantation | 1 | 2022 | 3110 | 0.340 |
Why?
|
Myocardial Ischemia | 2 | 2023 | 2148 | 0.330 |
Why?
|
Acute Coronary Syndrome | 1 | 2022 | 2337 | 0.320 |
Why?
|
Cardiac Imaging Techniques | 2 | 2019 | 269 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20129 | 0.260 |
Why?
|
Breast | 1 | 2014 | 1969 | 0.260 |
Why?
|
Inflammation | 3 | 2021 | 10638 | 0.250 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3068 | 0.240 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2282 | 0.240 |
Why?
|
Tuberculosis | 1 | 2017 | 1912 | 0.240 |
Why?
|
Retrospective Studies | 9 | 2023 | 77449 | 0.230 |
Why?
|
Rubidium | 1 | 2022 | 133 | 0.210 |
Why?
|
Exercise Test | 2 | 2020 | 2074 | 0.200 |
Why?
|
Oxytocics | 1 | 2021 | 68 | 0.190 |
Why?
|
Immunosuppressive Agents | 2 | 2023 | 4149 | 0.180 |
Why?
|
Feasibility Studies | 2 | 2020 | 5078 | 0.180 |
Why?
|
Obesity | 2 | 2023 | 12745 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 35421 | 0.180 |
Why?
|
Bursitis | 1 | 2021 | 83 | 0.180 |
Why?
|
Acetylcholine | 1 | 2022 | 621 | 0.180 |
Why?
|
Male | 18 | 2023 | 350118 | 0.180 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4933 | 0.180 |
Why?
|
Infarction | 1 | 2021 | 244 | 0.170 |
Why?
|
Calcaneus | 1 | 2021 | 138 | 0.170 |
Why?
|
ROC Curve | 2 | 2019 | 3527 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 1 | 2014 | 3143 | 0.170 |
Why?
|
Dideoxynucleosides | 1 | 2019 | 122 | 0.170 |
Why?
|
Achilles Tendon | 1 | 2021 | 157 | 0.160 |
Why?
|
Injections, Intravenous | 1 | 2021 | 1420 | 0.160 |
Why?
|
Aged | 12 | 2023 | 163280 | 0.160 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2018 | 44 | 0.160 |
Why?
|
Middle Aged | 12 | 2023 | 213383 | 0.160 |
Why?
|
Tendinopathy | 1 | 2021 | 154 | 0.160 |
Why?
|
American Heart Association | 1 | 2022 | 1056 | 0.150 |
Why?
|
Kidney Neoplasms | 1 | 2014 | 4262 | 0.150 |
Why?
|
Prognosis | 5 | 2023 | 29063 | 0.150 |
Why?
|
Prealbumin | 1 | 2019 | 210 | 0.150 |
Why?
|
Membrane Potentials | 1 | 2020 | 1137 | 0.150 |
Why?
|
Ontario | 1 | 2017 | 383 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19905 | 0.140 |
Why?
|
Plaque, Atherosclerotic | 2 | 2018 | 1519 | 0.130 |
Why?
|
Female | 15 | 2023 | 380194 | 0.130 |
Why?
|
Granuloma, Foreign-Body | 1 | 2015 | 45 | 0.130 |
Why?
|
Doxorubicin | 1 | 2022 | 2234 | 0.130 |
Why?
|
Plasmacytoma | 1 | 2016 | 183 | 0.130 |
Why?
|
Sodium | 1 | 2020 | 1623 | 0.130 |
Why?
|
Vasculitis | 1 | 2019 | 519 | 0.130 |
Why?
|
Chest Pain | 1 | 2022 | 1114 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2018 | 2073 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2015 | 588 | 0.120 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2013 | 136 | 0.110 |
Why?
|
Tissue Distribution | 1 | 2017 | 2327 | 0.110 |
Why?
|
Subcutaneous Tissue | 1 | 2013 | 135 | 0.110 |
Why?
|
Perfusion Imaging | 1 | 2014 | 195 | 0.110 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1150 | 0.110 |
Why?
|
Nuclear Medicine | 1 | 2015 | 233 | 0.100 |
Why?
|
Credentialing | 2 | 2022 | 126 | 0.100 |
Why?
|
Systole | 1 | 2014 | 958 | 0.100 |
Why?
|
Diastole | 1 | 2014 | 791 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2029 | 0.100 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.100 |
Why?
|
Rare Diseases | 1 | 2016 | 553 | 0.100 |
Why?
|
Radiotherapy Dosage | 1 | 2017 | 2879 | 0.100 |
Why?
|
Electrocardiography | 2 | 2022 | 6442 | 0.090 |
Why?
|
Adult | 6 | 2021 | 214055 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57776 | 0.090 |
Why?
|
Administration, Oral | 1 | 2017 | 3913 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1405 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2012 | 845 | 0.080 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.070 |
Why?
|
Hemodynamics | 1 | 2017 | 4199 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2917 | 0.070 |
Why?
|
Heart Conduction System | 1 | 2012 | 1047 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2016 | 1363 | 0.070 |
Why?
|
Diagnostic Imaging | 3 | 2015 | 3507 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2012 | 851 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 3670 | 0.060 |
Why?
|
Stroke Volume | 1 | 2018 | 5007 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2016 | 2725 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8949 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.060 |
Why?
|
Risk Factors | 3 | 2023 | 72290 | 0.060 |
Why?
|
Software | 1 | 2018 | 4443 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2017 | 12026 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2376 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11727 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2020 | 63114 | 0.050 |
Why?
|
Mitochondria, Heart | 1 | 2022 | 247 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.050 |
Why?
|
Nitrogen Isotopes | 1 | 2020 | 84 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2012 | 3821 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12959 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 239 | 0.040 |
Why?
|
Swine | 2 | 2020 | 5917 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1119 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1360 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2022 | 692 | 0.040 |
Why?
|
Animals | 5 | 2022 | 168757 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13881 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 40561 | 0.040 |
Why?
|
Microspheres | 1 | 2020 | 777 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4838 | 0.040 |
Why?
|
Lung | 1 | 2015 | 9856 | 0.040 |
Why?
|
Regional Blood Flow | 1 | 2020 | 1525 | 0.030 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2015 | 116 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.030 |
Why?
|
France | 1 | 2015 | 517 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2022 | 1637 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 981 | 0.030 |
Why?
|
Australia | 1 | 2015 | 1170 | 0.030 |
Why?
|
Child | 2 | 2017 | 77709 | 0.030 |
Why?
|
Patient Selection | 1 | 2023 | 4215 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 7023 | 0.020 |
Why?
|
Body Surface Potential Mapping | 1 | 2012 | 238 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2065 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18029 | 0.020 |
Why?
|
Models, Statistical | 1 | 2023 | 5102 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3339 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15165 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 20822 | 0.020 |
Why?
|
Dogs | 1 | 2012 | 3912 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3743 | 0.010 |
Why?
|
United States | 1 | 2022 | 69872 | 0.010 |
Why?
|